Form D Explorer

Inspect source fieldsReport a record issue

Form D — Ensho Therapeutics, Inc.

0002032849-25-000003 · filed Sep 12, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$22,500,000
Reported amount sold
$22,500,000
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Ensho Therapeutics, Inc.
CIK
2032849
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2024
Address
50 Tice Boulevard
Woodcliff Lake, New Jersey 07677
Phone
973-475-8970

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Other filings from this issuer

View the original filing on SEC EDGAR ↗